Literature DB >> 30851286

Stem cell paracrine effect and delivery strategies for spinal cord injury regeneration.

V Veneruso1, F Rossi2, A Villella1, A Bena1, G Forloni1, P Veglianese3.   

Abstract

Spinal cord injury (SCI) is a complicated neuropathological condition that results in functional dysfunction and paralysis. Various treatments have been proposed including drugs, biological factors and cells administered in several ways. Stem cell therapy offers a potentially revolutionary mode to repair the damaged spinal cord after injury. Initially, stem cells were considered promising for replacing cells and tissue lost after SCI. Many studies looked at their differentiation to replace neuronal and glial cells for a better functional outcome. However, it is becoming clear that different functional improvements recognized to stem cells are due to biomolecular activities by the transplanted stem cells rather than cell replacement. This review aimed to discuss the paracrine mechanisms for tissue repair and regeneration after stem cell transplantation in SCI. It focuses on stem cell factor production, effect in tissue restoration, and novel delivery strategies to use them for SCI therapy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biofactors; Secreted factors; Spinal cord injury; Stem cells

Mesh:

Year:  2019        PMID: 30851286     DOI: 10.1016/j.jconrel.2019.02.038

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

Review 1.  Extracellular Vesicles as an Emerging Frontier in Spinal Cord Injury Pathobiology and Therapy.

Authors:  Dipankar Dutta; Niaz Khan; Junfang Wu; Steven M Jay
Journal:  Trends Neurosci       Date:  2021-02-11       Impact factor: 16.978

2.  Rapid and effective treatment of traumatic spinal cord injury using stem cell derived exosomes.

Authors:  Jiafu Mu; Jiahe Wu; Jian Cao; Teng Ma; Liming Li; Shiqing Feng; Jianqing Gao
Journal:  Asian J Pharm Sci       Date:  2021-10-29       Impact factor: 6.598

Review 3.  Biomaterials reinforced MSCs transplantation for spinal cord injury repair.

Authors:  Teng Ma; Jiahe Wu; Jiafu Mu; Jianqing Gao
Journal:  Asian J Pharm Sci       Date:  2021-04-20       Impact factor: 6.598

4.  Significant Therapeutic Effects of Adult Human Neural Stem Cells for Spinal Cord Injury Are Mediated by Monocyte Chemoattractant Protein-1 (MCP-1).

Authors:  Chung Kwon Kim; Jeong-Seob Won; Jae Yeol An; Ho Jin Lee; Ah-Jin Nam; Hyun Nam; Ji Yeoun Lee; Kyung-Hoon Lee; Sun-Ho Lee; Kyeung Min Joo
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

Review 5.  Biomaterial-Mediated Factor Delivery for Spinal Cord Injury Treatment.

Authors:  Filippo Pinelli; Fabio Pizzetti; Valeria Veneruso; Emilia Petillo; Michael Raghunath; Giuseppe Perale; Pietro Veglianese; Filippo Rossi
Journal:  Biomedicines       Date:  2022-07-12

6.  Developmentally engineered bio-assemblies releasing neurotrophic exosomes guide in situ neuroplasticity following spinal cord injury.

Authors:  Jin Yan; Liqiang Zhang; Liya Li; Wangxiao He; Wenjia Liu
Journal:  Mater Today Bio       Date:  2022-08-24

7.  Hypoxia-pretreated mesenchymal stem cell-derived exosomes-loaded low-temperature extrusion 3D-printed implants for neural regeneration after traumatic brain injury in canines.

Authors:  Xiaoyin Liu; Jingjing Wang; Peng Wang; Lin Zhong; Shan Wang; Qingbo Feng; Xin Wei; Liangxue Zhou
Journal:  Front Bioeng Biotechnol       Date:  2022-09-30

Review 8.  Cell therapy and delivery strategies for spinal cord injury.

Authors:  Bruna Dos S Ramalho; Fernanda M de Almeida; Ana M B Martinez
Journal:  Histol Histopathol       Date:  2021-06-10       Impact factor: 2.303

Review 9.  Strategies and prospects of effective neural circuits reconstruction after spinal cord injury.

Authors:  Biao Yang; Feng Zhang; Feng Cheng; Liwei Ying; Chenggui Wang; Kesi Shi; Jingkai Wang; Kaishun Xia; Zhe Gong; Xianpeng Huang; Cao Yu; Fangcai Li; Chengzhen Liang; Qixin Chen
Journal:  Cell Death Dis       Date:  2020-06-08       Impact factor: 8.469

10.  Clinical and imaging outcomes after intrathecal injection of umbilical cord tissue mesenchymal stem cells in cerebral palsy: a randomized double-blind sham-controlled clinical trial.

Authors:  Man Amanat; Anahita Majmaa; Morteza Zarrabi; Masoumeh Nouri; Masood Ghahvechi Akbari; Ali Reza Moaiedi; Omid Ghaemi; Fatemeh Zamani; Sharif Najafi; Reza Shervin Badv; Massoud Vosough; Amir Ali Hamidieh; Mona Salehi; Hadi Montazerlotfelahi; Ali Reza Tavasoli; Morteza Heidari; Hossein Mohebi; Ali Fatemi; Amir Garakani; Mahmoud Reza Ashrafi
Journal:  Stem Cell Res Ther       Date:  2021-08-06       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.